An Assessment of the Use of Enoxaparin/Warfarin vs. Enoxaparin/ Rivaroxaban in Patients with Gynecologic Cancer Co and Venous Thromboembolism | Zendy

AI Assistant Blog Pricing

Open Access

An Assessment of the Use of Enoxaparin/Warfarin vs. Enoxaparin/ Rivaroxaban in Patients with Gynecologic Cancer Co and Venous Thromboembolism

Author(s) -

Marcos José Pereira Renni,

AUTHOR_ID,

I Bergmann,

AUTHOR_ID

Publication year - 2021

Language(s) - English

DOI - 10.47363/jcrr/2021(3)128

Subject(s) - medicine , rivaroxaban , venous thromboembolism , warfarin , cancer , gynecologic cancer , thrombosis , ovarian cancer , atrial fibrillation

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Empowering knowledge with every search

About

About Careers Publisher Partners Contact Us

Learn

FAQs Blog Terms of Use Privacy Policy

Discover

Explore

Copyright Knowledge E © 2025. All Rights Reserved.